More than 10 years of approved clinical use in the US1
	Evidence of a therapeutic response can be seen in a few days as an increase in reticulocyte count
	Removal by dialysis is negligible

	INFeD should be used only in those patients in whom the indications have been clearly established and laboratory investigations confirm an iron-deficient state not amenable to oral iron therapy.
	Test dose is required.
	The parenteral use of complexes of iron and carbohydrates has resulted in anaphylactic-type reactions. Deaths associated with such administration have been reported.
	Because fatal anaphylactic reactions have been reported after administration of iron dextran injection, the drug should be given only when resuscitation techniques and treatment of anaphylactic and anaphylactoid shock are readily available.

Please see references and complete Prescribing Information under WARNINGS, PRECAUTIONS and ADVERSE REACTIONS including BOXED WARNING for a complete listing of side effects.